Sialic acid levels in liver cancer
Part of Cancer, Digestive system clinical trials.
This study looks at sialic acid, a substance in the blood, in people with liver cancer (hepatocellular carcinoma) and compares it with people who have liver cirrhosis or are healthy. It may help doctors understand liver cancer better and find new ways to monitor it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You may have liver cancer, liver cirrhosis, or be a healthy person without liver disease.
- You must not have any other type of cancer besides liver cancer.
- You must not have had previous treatment for liver cancer, like surgery, radiation, or chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study is for people having liver cancer surgery. It will look at certain fats in your blood to see if they can help doctors understand and track liver cancer better.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
This study looks at genetic markers in the blood of people with liver cancer who are having surgery, either right away or after some treatment first. It aims to find out why some patients do better, which could help personalize care.
This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.